ENPP1 affects insulin action and secretion: Evidences from in vitro studies

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Di Paola, Rosa ^a   Caporarello, Nunzia ^b   Marucci, Antonella ^a   Dimatteo, Claudia ^a   Iadicicco, Claudia ^c   Del Guerra, Silvia ^d   Prudente, Sabrina ^a   Sudano, Dora ^b   Miele, Claudia ^c   Parrino, Cristina ^b   Piro, Salvatore ^b   Beguinot, Francesco ^c   Marchetti, Piero ^d   Trischitta, Vincenzo ^a,e   Frittitta, Lucia ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; DEOXYGLUCOSE; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; GLIBENCLAMIDE; GLUCOSE TRANSPORTER 4; GLUTAMINE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR; LYSINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHODIESTERASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE; INORGANIC PYROPHOSPHATASE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL ISOLATION; CELL STRAIN HEPG2; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC TRANSFECTION; GENETIC VARIABILITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HETEROZYGOTE; HOMOZYGOSITY; HORMONE ACTION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MUSCLE CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; CELL LINE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; PANCREAS ISLET; PHOSPHORYLATION; SECRETION;

CELL LINE; GENOTYPE; GLUCOSE; GLYBURIDE; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; POLYMORPHISM, GENETIC; PYROPHOSPHATASES;

EID: 79955872917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019462     Document Type: Article

References (54)

1. DeFronzo RA, (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687.
2. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR, (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915.
3. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992.
4. Virkamaki A, Ueki K, Kahn CR, (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-943.
5. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, et al. (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329-339.
6. Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, et al. (2004) Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 286: E41-E49.
7. Okada T, Liew CW, Hu J, Hinault C, Michael MD, et al. (2007) Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 104: 8977-8982.
8. Liew CW, Bochenski J, Kawamori D, Hu J, Leech CA, et al. (2010) The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest 120: 2876-2888.
9. Almind K, Inoue G, Pedersen O, Kahn CR, (1996) A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97: 2569-2575.
10. Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, et al. (2000) The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85: 2004-2013.
11. Prudente S, Hribal ML, Flex E, Turchi F, Morini E, et al. (2005) The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54: 2807-2811.
12. Andreozzi F, Formoso G, Prudente S, Hribal ML, Pandolfi A, et al. (2008) TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol 28: 1355-1360.
13. Prudente S, Baratta R, Andreozzi F, Morini E, Farina MG, et al. (2010) TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 53: 1354-1361.
14. Clausen JO, Hansen T, Bjørbaek C, Echwald SM, Urhammer SA, et al. (1995) Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346: 397-402.
15. Stumvoll M, Fritsche A, Volk A, Stefan N, Madaus A, et al. (2001) The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes 50: 882-885.
16. Prudente S, Scarpelli D, Chandalia M, Zhang YY, Morini E, et al. (2009) The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 94: 190-196.
17. Marchetti P, Lupi R, Federici M, Marselli L, Masini M, et al. (2002) Insulin secretory function is impaired in isolated human islets carrying the Gly(972)→Arg IRS-1 polymorphism. Diabetes 51: 1419-1424.
18. Porzio O, Federici M, Hribal ML, Lauro D, Accili D, et al. (1999) The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 104: 357-364.
19. Kahn CR, (2003) Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp Diabesity Res 4: 169-182.
20. Prudente S, Morini E, Trischitta V, (2009) Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol 5: 682-693.
21. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, et al. (2008) The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 29: 62-75.
22. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, et al. (1995) Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373: 448-451.
23. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, et al. (1996) Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10: 1318-1326.
24. Maddux BA, Goldfine ID, (2000) Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 49: 13-19.
25. Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, et al. (2001) The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 50: 831-836.
26. Liang J, Fu M, Ciociola E, Chandalia M, Abate N, (2007) Role of ENPP1 on adipocyte maturation. PLoS One 2: e882.
27. Chin CN, Dallas-Yang Q, Liu F, Ho T, Ellsworth K, et al. (2009) Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity. Eur J Pharmacol 606: 17-24.
28. Dong H, Maddux BA, Altomonte J, Meseck M, Accili D, et al. (2005) Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes 54: 367-372.
29. Maddux BA, Chang YN, Accili D, McGuinness OP, Youngren JF, et al. (2006) Overexpression of the Insulin Receptor Inhibitor, PC-1/NPP1, Induces Insulin Resistance and Hyperglycemia. Am J Physiol Endocrinol Metab 290: E746-749.
30. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, et al. (1997) Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 40: 282-289.
31. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, et al. (1998) Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes 47: 1095-1100.
32. Teno S, Kanno H, Oga S, Kumakura S, Kanamuro R, et al. (1999) Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulin-dependent diabetes mellitus patients with insulin resistance. Diabetes Res Clin Pract 45: 25-30.
33. Stentz FB, Kitabchi AE, (2007) Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 5: 216-235.
34. Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, et al. (1999) A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48: 1881-1884.
35. Abate N, Carulli L, Cabo-Chan A Jr, Chandalia M, Snell PG, et al. (2003) Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 88: 5927-5934.
36. Stolerman ES, Manning AK, McAteer JB, Dupuis J, Fox CS, et al. (2008) Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 57: 1971-1977.
37. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, et al. (2008) Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 57: 3360-3364.
38. Grarup N, Urhammer SA, Ek J, Albrechtsen A, Glumer C, et al. (2006) Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 49: 2097-2104.
39. Bacci S, Rizza S, Prudente S, Spoto B, Powers C, et al. (2011) The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes 60: 1000-1007.
40. Bacci S, Di Paola R, Menzaghi C, Di Fulvio P, Di Silvestre S, et al. (2009) ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol 29: 1678-1683.
41. Zhou HH, Chin CN, Wu M, Ni W, Quan S, et al. (2009) Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur J Pharmacol 616: 346-352.
42. Aspinwall CA, Qian WJ, Roper MG, Kulkarni RN, Kahn CR, et al. (2000) Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem 275: 22331-22338.
43. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, et al. (2004) Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114: 928-936.
44. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
45. Marucci A, Miscio G, Padovano L, Boonyasrisawat W, Florez JC, et al. (2009) The role of HSP70 on ENPP1 expression and insulin-receptor activation. J Mol Med 87: 139-144.
46. Oriente F, Iovino S, Cabaro S, Cassese A, Longobardi E, et al. (2011) Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 60: 138-147.
47. Miele C, Riboulet A, Maitan MA, Oriente F, Romano C, et al. (2003) Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism. J Biol Chem 278: 47376-47387.
48. Raciti GA, Iadicicco C, Ulianich L, Vind BF, Gaster M, et al. (2010) Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia 53: 955-965.
49. Anello M, Spampinato D, Piro S, Purrello F, Rabuazzo AM, (2004) Glucosamine-induced alterations of mitochondrial function in pancreatic B-cells: possible role of protein glycosilation. Am J Physiol Endocrinol Metab 287: E602-E608.
50. Parker JC, VanVolkenburg MA, Gao F, (2004) Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor. Life Sci 75: 1479-1490.
51. Clare L, Kirkpatrick CL, Marchetti P, Purrello F, Piro S, et al. (2010) Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors. PLoS One 5: e11053.
52. Marchetti P, Bugliani M, Lupi R, Marselli L, Masini M, et al. (2007) The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50: 2486-2494.
53. Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, et al. (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54: 727-735.
54. Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, et al. (2005) Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 90: 501-506.